Structured intelligence on corporate strategy, market moves, and industry signals.
Each entry is a briefing, not a headline: event summary, strategic context, and what to watch next.
A Company Pulse is our reading of what a company says in its own press release, with the questions we would want answered. It is not verified reporting and it is not an endorsement. Pulses are made from press releases we collect from several sources, including Wire. Nobody can pay for a Pulse.
Genentech exercised its first Validated Target Option under the neuroscience collaboration, advancing a previously unexplored target into an early discovery program.
Compass Pathways reported Q2 2026 revenue and progress toward FDA filing for COMP360, its psilocybin treatment for treatment-resistant depression (TRD).
